Abeona Therapeutics (ABEO) EBITDA Margin (2011 - 2026)
Abeona Therapeutics (ABEO) recorded EBITDA Margin of -114.13% in Q2 2026, up 5447.87 percentage points from -5562.00% a year earlier and up 142.10 percentage points from the prior quarter.
Powered by 
Analysis
Abeona Therapeutics (ABEO) EBITDA Margin (2011 - 2026) Analysis & Trends
On a TTM basis, Abeona Therapeutics' EBITDA Margin came in at -316.57% as of Jun 30, 2026, up 17791.43 percentage points year-over-year; for FY2025, it came in at -1493.11%.
- Annual EBITDA Margin has a five-year change of -724.77 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -1281.34% in FY2023 (+2100.69 pp), -3382.04% in FY2022 (-495.84 pp) and -2886.20% in FY2021 (-2117.86 pp).
- The Q2 2026 figure is the highest quarterly EBITDA Margin since Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 39.16% |
| 10 | Abeona Therapeutics | 251.30 Mn | -462.66 Mn | 7.20 Mn | -114.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -114.13% |
| Mar 31, 2026 | -256.23% |
| Dec 31, 2025 | -406.79% |
| Jun 30, 2025 | -5,562.00% |
| Jun 30, 2023 | -283.97% |
| Dec 31, 2022 | -17,951.47% |
| Jun 30, 2022 | -723.50% |
| Mar 31, 2022 | -5,716.76% |
| Dec 31, 2020 | -454.67% |
| Sep 30, 2020 | -77.16% |
| Dec 31, 2018 | -3,447.93% |
| Sep 30, 2018 | -960.27% |
| Jun 30, 2018 | -4,444.57% |
| Mar 31, 2018 | -1,979.10% |
| Dec 31, 2017 | -4,001.86% |
| Sep 30, 2017 | -2,385.39% |
| Jun 30, 2017 | -3,794.01% |
| Mar 31, 2017 | -2,706.45% |
| Dec 31, 2016 | -2,181.25% |
| Sep 30, 2016 | -2,691.30% |
API Access
Abeona Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ABEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();